The performance of companies tied to flagship drugs like Viagra presents a nuanced investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key territories has introduced significant risk . Investors are now grappling with the impact of generic competition , r